Results 61 to 70 of about 392,626 (135)

Utilizing ¹³C-Labeled internal standards to advance the analysis of heparan sulfate. [PDF]

Am J Physiol Cell Physiol
Wang Z, Liu J.
europepmc   +1 more source

Heparina de alto peso molecular. Uma alternativa nas operações com circulação extracorpórea: estudo experimental [PDF]

Ayrton BERTINI Jr., Carl P. DIETRICH, Clodualdo J. N. PESSA, Dayse M. LOURENÇO, Enio BUFFOLO, Helena B. NADER, João Nelson R. BRANCO, Roberto CATANI, Walter J. GOMES   +8 more
core   +1 more source

THE DEMONSTRATION OF THE INDIVIDUAL ACID MUCOPOLYSACCHARIDES IN HUMAN AORTAS, CORONARY ARTERIES AND CEREBRAL ARTERIES. I. THE METHODS

, 1962
F. Zugibe
semanticscholar   +1 more source

Pathology of Cardiac Valves

Journal of cardiology. Supplement, 1981
R. Okada
semanticscholar   +1 more source

Diversity of human salivary heparan sulfate. [PDF]

Glycobiology
Spliid CB, Mehta S, Fuster MM, Martino C, Morris CL, Lee N, Florentino I, Tong K, Liu L, Ackermann G, Knight R, Esko JD, Hurtado de Mendoza T.   +12 more
europepmc   +1 more source

Splice Variant of Spalax Heparanase Skipping Exon 12. [PDF]

Genes (Basel)
Nasser NJ, Nevo E, Avivi A.
europepmc   +1 more source

Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor. [PDF]

Cell Commun Signal
Ciura K, Sobota O, Chorążewska A, Krowarsch D, Porębska N, Opaliński Ł.   +5 more
europepmc   +1 more source

Heparan sulfate in cerebrospinal fluid as a biomarker to assess disease severity and for treatment monitoring in patients with Mucopolysaccharidosis Type II: a position statement. [PDF]

Orphanet J Rare Dis
Giugliani R, de Siqueira ACM, Santos ES, Leão EKEA, Carvalho GDS, Santos MLSF, Raskin S, Martins AM.   +7 more
europepmc   +1 more source

Genetic Variance in Heparan Sulfation Is Associated With Salt Sensitivity. [PDF]

Hypertension
Oppelaar JJ, Ferwerda B, Romman MA, Sahebdin GN, Zwinderman AH, Galenkamp H, Boekholdt SM, van den Born BH, Olde Engberink RHG, Vogt L.   +9 more
europepmc   +1 more source

mRNA Degradation as a Therapeutic Solution for Mucopolysaccharidosis Type IIIC: Use of Antisense Oligonucleotides to Promote Downregulation of Heparan Sulfate Synthesis. [PDF]

Int J Mol Sci
Santos JI, Gonçalves M, Almeida MB, Rocha H, Duarte AJ, Matos L, Moreira LV, Encarnação M, Gaspar P, Prata MJ, Coutinho MF, Alves S.   +11 more
europepmc   +1 more source